NCT06205199View on ClinicalTrials.gov

Analgesic Effect of Ropivacaine Combined With Hydromorphone for CSEA After Total Knee Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

October 27, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Postoperative Analgesia
Interventions
DRUG

Hydromorphone was injected into the subarachnoid space

The dose of hydromorphone is 50 micrograms

Trial Locations (1)

Unknown

Second Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Second Hospital of Jilin University

OTHER